| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |